home / stock / sngx / sngx news


SNGX News and Press, Soligenix Inc. From 09/14/21

Stock Information

Company Name: Soligenix Inc.
Stock Symbol: SNGX
Market: NASDAQ
Website: soligenix.com

Menu

SNGX SNGX Quote SNGX Short SNGX News SNGX Articles SNGX Message Board
Get SNGX Alerts

News, Short Squeeze, Breakout and More Instantly...

SNGX - Soligenix Develops Groundbreaking Vaccine Platform to Target Future Pandemics

Soligenix discusses its contribution to addressing future serious public health threats in a podcast New York, New York--(Newsfile Corp. - September 14, 2021) - PCG Digital -- The COVID-19 pandemic has already cost the United States an estimated $16 trillion in lost economic output , and has...

SNGX - LULU, FRO and PMCB among pre market gainers

Soligenix (NASDAQ:SNGX) +26% FDA Grants soligenix orphan drug designation for the treatment of T-cell lymphoma Eloxx Pharmaceuticals (NASDAQ:ELOX) +22% announces fast track designation for ELX-02 for the treatment of cystic fibrosis patients with nonsense mutations Cardiff Oncology ...

SNGX - FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma

FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma PR Newswire PRINCETON, N.J. , Sept. 9, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Solig...

SNGX - MDB, MMAT and SNGX among pre market gainers

Cellect Biotechnology (NASDAQ:APOP) +69% after reporting first ApoGraft Bone Marrow Transplantation in U.S. PagerDuty (NYSE:PD) +15% on Q2 earnings. Enveric Biosciences (NASDAQ:ENVB) +15%. MongoDB (NASDAQ:MDB) +14%. Sinopec Shanghai Petrochemical (NYSE:SHI) +13%. The OLB (NASDAQ:OLB...

SNGX - Soligenix: Developing Tools to Tackle the Next Potential Pandemic; PCG Digital Biotech Watch Review

Soligenix: Developing Tools to Tackle the Next Potential Pandemic; PCG Digital Biotech Watch Review PR Newswire NEW YORK , Aug. 24, 2021 /PRNewswire/ -- Vaccines are known for the stringent cold chain storage requirements necessary to maintain their integrity. In...

SNGX - Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases

Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases Single-vial vaccine platform demonstrates high antibody levels against three lethal viruses PR Newswire ...

SNGX - Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates

Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates - Potent efficacy data using purified antigens and CoVaccine HT™ adjuvant demonstrated in non-human primates (NHPs) published in Frontiers in Immunology - Thermostabil...

SNGX - Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results

Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results PR Newswire PRINCETON, N.J. , Aug. 13, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developin...

SNGX - Who Is Preparing Us for the Next Potential Pandemic?

New York, New York--(Newsfile Corp. - July 29, 2021) - -- PCG Digital -- Dr. Fauci said it publicly this week, but we've all been thinking it for months now. COVID-19 did not hit us, "out of the blue." Scientists, medical professionals, and researchers have been expecting this for years. The g...

SNGX - HyBryte(TM): Addressing an Unmet Need for Rare Lymphoma

Soligenix Demonstrates Clinical Success in First-in-Class Treatment for Cutaneous T-Cell Lymphoma   New York, NY - ( NewMediaWire ) - July 22, 2021 - PCG Digital -- Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin’s lymphoma that currently affects between...

Previous 10 Next 10